Visual dysfunction and work invalidity in patients with diabetes and hypertension

  • Vesna Krstović Spremo Univerzitet u Istočnom Sarajevu, Medicinski fakultet Foča, Republika Srpska, Bosna i Hercegovina
  • Divna Kekuš
Ključne reči: diabetes, hypertension, visual disturbance

Sažetak


Diabetes mellitus and arterial hypertension are chronic, mass non-communicable diseases that are global health problems with characteristics of epidemiology and consecutive eye complications are the common reason for visual handicap and disability in the work productive population.

Objective: The primary aim was to analyze the frequency of visual dysfunction, and behavioral habits in diabetic and hypertensive patients and the second aim was to analyze the occurrence of work disability in patients with these diseases.

Methods:  The investigation is a cross-sectional study made in two Health Centers in the City of Eastern Sarajevo in a period of July 2018 to July 2019 (12 months). A randomized sample of 192 patients with diabetes and 100 hypertensive patients. For this purpose is created a special questionnaire, and statistic analysis is made by SPSS (IBM, Chicago version 19). Statistical significance was investigated with χ 2 test.

Results: Diabetic patients significantly have more visual disturbances than hypertensive patients according to subjective assessment (χ2= 14.21, p< 0.001). Worsening of visual acuity is presented more in diabetic than in hypertensive patients (χ2 = 16.17, p < 0.001). There is no significant difference in behavioral habits between diabetic and hypertensive patients for smoking (χ2 =1.778, p=0.411) and alcohol consumption.( χ2 = 2.158, p = 0.142). Patients with diabetes are more frequent in the status of work disability than those with hypertension  (χ2 = 13,46, p < 0,001).

Conclusion: Mass non-communicable diseases are a common cause of visual dysfunction and diabetes mellitus is the main reason for visual disability in the adult population from the region of Eastern Sarajevo. Behavioral habits like smoking and alcohol consumption have a serious impact on  the prognosis of those patients.

Reference

1. Guariguata L, Whiting DR, Hambleton, I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014; 103:137–49.
2. ADA Winning at Work–Diabetes Facts: What Diabetes Costs Your Workplace Available from: http:www.diabetes.org/diabetes-facts :Economic costs of diabetes in the U.S in 2017 Diabetes Care, 2018; 41:917-928.
3. Andersson, E. et al. Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden, Diabetologia; Springer, 2020; 2582-2594.
4. Bommer C, Heessemann E, Sagalova V, et al.: The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study. Lancet Diabetes Endocrinol 2017; 5:423-30
5. Zuo H, Shi Z, Hussain Prevalence, trends and risk factors for the diabetes epidemic in China: a systematic review and meta-analysis. Diabetes Res Clin Pract 2014;104:63-72.
6. Global action plan for the prevention and control of noncommunicable diseases 2013-2020. Geneva: World Health Organization; 2013. available from: http// www.vho.int (last accessed 17.11.2019.)
7. Ceklić, L, Latinović S, Aleksić P. [Leading causes of blindness and visual impairment in the region of Eastern Herzegovina]. Med Pregl. 2006 Jan-Feb; 59 (1-2):15-8.
8. Zheng Y, He M, Congdon N. The worldwide epidemic of diabetic retinopathy. Indian J Ophthalmol 2012; 60: 428-31.
9. IDF Diabetes Atlas the 7-th edition Brussels 2016: available from: http// www. idf.org (last accessed 17.11.2019.)
10. Das A, Diabetic retinopathy: Battling the global epidemic. Indian J Ophthalmol. 2016 Jan; 64(1):2-3.
11. Forbes JM: Mark E. Cooper ME. Mechanisms of Diabetic Complications Physiological Reviews Published 1 January 2013 Vol. 93 no. 1, 137-188
12. Xu J, Wei WB, Yuan MX, Yuan SY, Wan G, et al. (2012) Prevalence and risk factors for diabetic retinopathy: the Beijing Communities Diabetes Study 6. Retina 32: 322–329
13. Do DV, Wang X, Vedula SS, Marrone M, Sleilati G, Hawkins BS, Frank RN Blood pressure control for diabetic retinopathy, Cohrane Reviews 2015, Issue 1. Art.N0CD06127.
14. Klein R, Lee KE, Gangnon RE, Klein BE. Relation of smoking, drinking, and physical activity to changes in vision over a 20-year period: the Beaver Dam Eye Study. Ophthalmology. 2014 Jun;121 (6):1220-8. doi: 10.1016/j.ophtha.2014.01.003.
15. Valencia WM, Florez H. How to prevent the microvascular complications of type 2 diabetes beyond glucose control.BMJ. 2017 Jan 17;356:i6505. doi: 10.1136/bmj.i6505. Review.
16. Forga L, Goñi MJ, Ibáñez B, Cambra K, García-Mouriz M, Iriarte A.Influence of Age at Diagnosis and Time-Dependent Risk Factors on the Development of Diabetic Retinopathy in Patients with Type 1 Diabetes.J Diabetes Res. 2016;2016:9898309. doi: 10.1155/2016/9898309.
17. Inoue R, Sumitani M, Yasuda T, Tsuji M, Nakamura M, Shimomura I, Shibata M, Yamada Y.Independent Risk Factors for Positive and Negative Symptoms in Patients with Diabetic Polyneuropathy. J Pain Palliat Care Pharmacother. 2016 Sep;30(3):178-83. doi: 10.1080/15360288.2016.1192081.
18. Tóth G, Szabó D, Sándor GL, Pék A, Szalai I, Lukács R, Tóth GZ, Papp A, Nagy ZZ, Limburg H, Németh J. [Regional disparities in the prevalence of diabetes and diabetic retinopathy in Hungary in people aged 50 years and older]. Orv Hetil. 2017 Mar;158 (10):362-367. doi: 10.1556/650.2017.30692. Hungarian.
19. Mathur R, Bhaskaran K, Edwards E, Lee H, Chaturvedi N, Smeeth L, Douglas I.Population trends in the 10-year incidence and prevalence of diabetic retinopathy in the UK: a cohort study in the Clinical Practice Research Datalink 2004-2014.BMJ Open. 2017 Feb 28;7(2):e014444. doi: 10.1136/bmjopen-2016-014444.
20. Scanlon PH.The English National Screening Programme for diabetic retinopathy 2003-2016.Acta Diabetol. 2017 Feb 22. doi: 10.1007/s00592-017-0974-1. [Epub ahead of print]
21. Romero-Aroca P, Navarro-Gil R, Valls-Mateu A, Sagarra-Alamo R, Moreno-Ribas A, Soler N.Differences in incidence of diabetic retinopathy between type 1 and 2 diabetes mellitus: a nine-year follow-up study.Br J Ophthalmol. 2017 Mar 7. pii: bjophthalmol-2016-310063. doi: 10.1136/bjophthalmol-2016-310063. [Epub ahead of print]

Objavljeno
2023/04/02
Rubrika
Originalni naučni članak